These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


71 related items for PubMed ID: 365798

  • 1. Analysis of a certain type of 2 x 3 tables, exemplified by biopsy findings in a controlled clinical trial.
    Scheiber V, Wohlzogen FX.
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):533-5. PubMed ID: 365798
    [Abstract] [Full Text] [Related]

  • 2. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J, Deák G, Müzes G, Láng I, Niederland V, Nékám K, Kárteszi M.
    Orv Hetil; 1989 Dec 17; 130(51):2723-7. PubMed ID: 2574842
    [Abstract] [Full Text] [Related]

  • 3. [Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author's transl)].
    Kiesewetter E, Leodolter I, Thaler H.
    Leber Magen Darm; 1977 Oct 17; 7(5):318-23. PubMed ID: 926982
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
    Trinchet JC, Coste T, Lévy VG, Vivet F, Duchatelle V, Legendre C, Gotheil C, Beaugrand M.
    Gastroenterol Clin Biol; 1989 Oct 17; 13(2):120-4. PubMed ID: 2707520
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW, Haase W.
    Schweiz Rundsch Med Prax; 1975 Sep 09; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Panel discussion on clinical trials: design.
    Forssman L.
    Rheumatol Rehabil; 1978 Sep 09; Suppl():126-8. PubMed ID: 364603
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Controlled study of the effect of silymarin on alcoholic liver disease].
    Bunout D, Hirsch S, Petermann M, de la Maza MP, Silva G, Kelly M, Ugarte G, Iturriaga H.
    Rev Med Chil; 1992 Dec 09; 120(12):1370-5. PubMed ID: 1343377
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Use of citiolone in chronic hepatitides. Results of a research with clinical and laboratory controls].
    Miglio F, D'Ambro A, Stefanini GF, Corazza GR, Pesa O, Flacco L, Schiavone C, Gasbarrini G.
    Minerva Med; 1977 Sep 30; 68(46):3177-92. PubMed ID: 917333
    [Abstract] [Full Text] [Related]

  • 16. [Clinical characteristics of forms of chronic hepatitis].
    Markiewicz K, Bubiński R.
    Dtsch Z Verdau Stoffwechselkr; 1985 Sep 30; 45(2):76-82. PubMed ID: 4006842
    [Abstract] [Full Text] [Related]

  • 17. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.
    Porter HP, Simon FR, Pope CE, Volwiler W, Fenster LF.
    N Engl J Med; 1971 Jun 17; 284(24):1350-5. PubMed ID: 4930603
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Multiple practice research. Experience with some methods].
    Bennedsen H, Nielsen JV.
    Ugeskr Laeger; 1979 May 28; 141(22):1482-4. PubMed ID: 377745
    [No Abstract] [Full Text] [Related]

  • 20. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.
    Fundam Clin Pharmacol; 2009 Jun 28; 23(3):359-65. PubMed ID: 19453758
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.